Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities

Honeywell Technologies (HON) will provide process technologies and services to Hengyi Industries for its Brunei petrochemical project, aiming to increase efficiency and higher-value production. The Phase II project is expected to process 20 million metric tons of crude annually. Hengyi Industries is a private company, not publicly traded.

Netflix has dismissed film chief Dan Lin, following the recent layoff of 1,000 employees. Chief content officer Bela Bajaria also left, with Peter Rice taking over. Netflix's stock has fallen over 40% in the past year, facing competition from free ad-supported streaming services. The company is set to report Q3 earnings on Tuesday.

Veradermics' stock rose 6% after its Phase III trial for male hair loss drug VDPHL01 met all endpoints, showing significant hair growth vs. placebo. The drug was well-tolerated, with 78.8% and 85.0% of patients reporting improvement in once-daily and twice-daily arms, respectively. Veradermics aims for FDA approval, potentially becoming the first oral pill for pattern hair loss in 30 years.

HSBC's Islamic Global Equity Index Fund, with $8bn in assets, invested over $130m in companies linked to Israel's military, including Palantir and RTX, raising questions about compliance with Islamic principles. The fund's Sharia committee oversees investments, but critics argue there's a tension between stated restrictions and reported investments.

Cantor Fitzgerald raised its price target on GoDaddy (GDDY) to $100 from $90, though it remains below the stock's $105.96 close. The firm expects Q3 results and Q4 guidance to meet estimates, with focus on GoDaddy's AI agent developer platform. Shares fell 0.39% in premarket trading.

BTIG reiterated a Buy rating on Spyre Therapeutics with a $121 price target, implying a 51.4% upside from the Oct 16 close. The firm cited positive Phase 2b data for tulisokibart and a strong pipeline in immune-mediated diseases.